Season sells SRPT 20.58: Sarepta Therapeutics Now Covered by Analysts at Bank of America (SRPT)
Analysts at Bank of America began coverage on shares of Sarepta Therapeutics (NASDAQ:SRPT) in a research report issued to clients and investors on Tuesday. The firm set a âneutralâ rating and a $27.00 price target on the stock. Bank of Americaâs ... ...
39 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home